Kardigan CSO reports initial stock option holdings
Kardigan, Inc. reported the initial holdings of Chief Strategy Officer Andy Pasternak on Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Kardigan, Inc. reported the initial holdings of Chief Strategy Officer Andy Pasternak on Form 3. He holds stock options to acquire 358,380 shares of common stock indirectly through The Andrew J. Pasternak Spousal Lifetime Access Trust and 31,339 shares directly, all at an exercise price of $14.71 per share. The options expire on September 30, 2035 and February 9, 2036 and vest over time starting on August 1, 2025 and January 1, 2027, subject to continued service.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Pasternak Andy
Role
Chief Strategy Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 31,339 contracts (Direct);
Stock Option (right to buy) — 358,380 contracts (Indirect, By The Andrew J. Pasternak Spousal Lifetime Access Trust)
Footnotes (2)
- F1. The shares subject to this option shall vest and become exercisable in twelve (12) equal monthly installments commencing from August 1, 2025, subject to the Reporting Person's continued service on each such vesting date.
- F2. 25% of the shares subject to this option shall vest and become exercisable on January 1, 2027 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Indirect option underlying shares: 358,380 shares
Direct option underlying shares: 31,339 shares
Option exercise price: $14.71/share
+4 more
7 metrics
Indirect option underlying shares
358,380 shares
Underlying common stock for indirectly held options reported on Form 3
Direct option underlying shares
31,339 shares
Underlying common stock for directly held options reported on Form 3
Option exercise price
<money>$14.71</money>/share
Exercise price for both indirect and direct stock options
Indirect option expiration
<date>February 9, 2036</date>
Expiration date of indirectly held stock options
Direct option expiration
<date>September 30, 2035</date>
Expiration date of directly held stock options
First vesting start
<date>August 1, 2025</date>
Start of 12 equal monthly vesting installments for one grant
Second grant cliff vest
25% on <date>January 1, 2027</date>
Initial vesting portion of second option grant before monthly installments
Key Terms
Stock Option (right to buy), Spousal Lifetime Access Trust, vesting, exercise price, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Spousal Lifetime Access Trust financial
"By The Andrew J. Pasternak Spousal Lifetime Access Trust"
vesting financial
"shall vest and become exercisable in twelve (12) equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: 14.7100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-02-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kardigan (KARD) disclose about Andy Pasternak’s holdings on this Form 3?
Kardigan discloses that Chief Strategy Officer Andy Pasternak holds stock options over 358,380 shares indirectly and 31,339 shares directly. These options relate to common stock and establish his initial reportable equity position as an insider at the company.
What is the exercise price of Andy Pasternak’s Kardigan (KARD) stock options?
All reported Kardigan stock options held by Andy Pasternak have a $14.71 per share exercise price. This fixed price is what must be paid to convert the options into common stock when they vest and become exercisable in the future.
When do Andy Pasternak’s Kardigan (KARD) stock options vest?
One option grant vests in twelve equal monthly installments beginning August 1, 2025, subject to continued service. Another grant vests 25% on January 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, also contingent on ongoing service.
When do Andy Pasternak’s Kardigan (KARD) stock options expire?
The indirectly held Kardigan stock options expire on February 9, 2036, while the directly held options expire on September 30, 2035. After these expiration dates, any unexercised options will no longer be available to convert into common shares.
How are Andy Pasternak’s Kardigan (KARD) options held from an ownership standpoint?
Pasternak’s Kardigan options are split between indirect and direct ownership. 358,380 underlying shares are held indirectly through The Andrew J. Pasternak Spousal Lifetime Access Trust, while 31,339 underlying shares are held directly in his own name, as disclosed on Form 3.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates